CoChat

Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase

Open access

The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index; 12 of the 76 sources its claims cite were checked for support.

Abstract

Insulin action in the human brain modulates eating behaviour, whole-body metabolism and body fat distribution 1,2 . In particular, brain insulin action increases whole-body insulin sensitivity, but these studies were mainly performed in lean men 3,4 . Here we investigate metabolic and hypothalamic effects of brain insulin action in women with a focus on the impact of menstrual cycle ( ClinicalTrials.gov registration: NCT03929419 ). Eleven women underwent four hyperinsulinemic–euglycemic clamps, two in the follicular phase and two in the luteal phase. Brain insulin action was introduced using nasal insulin spray 5–7 and compared to placebo spray in a fourfold crossover design with change in glucose infusion rate as the primary endpoint. Here we show that during the follicular phase, more glucose has to be infused after administration of nasal insulin than after administration of placebo. This remains significant after adjustment for blood glucose and insulin. During the luteal phase, no significant influence of brain insulin action on glucose infusion rate is detected after adjustment for blood glucose and insulin (secondary endpoint). In 15 other women, hypothalamic insulin sensitivity was assessed in a within-subject design by functional magnetic resonance imaging with intranasal insulin administration 8 . Hypothalamus responsivity is influenced by insulin in the follicular phase but not the luteal phase. Our study therefore highlights that brain insulin action improves peripheral insulin sensitivity also in women but only during the follicular phase. Thus, brain insulin resistance could contribute to whole-body insulin resistance in the luteal phase of the menstrual cycle.

Overview

CoChat Summary

TL;DR

In healthy naturally cycling women, intranasal insulin improved peripheral insulin sensitivity during the follicular phase but not the luteal phase. A separate fMRI study found hypothalamic cerebral blood flow responses to insulin in the follicular phase only, although the phase-by-spray interaction was not significant.

Key findings

  • In 11 women, spray-induced changes in glucose infusion rate differed by cycle phase (t₁,₀₇₅ = 2.85, P = 0.004; adjusted for glucose and insulin: t₄₆₄ = 2.53, P = 0.01). During the follicular phase, glucose infusion rate increased more after nasal insulin than placebo (t₅₂₅ = −6.83, P < 0.0001; adjusted t₂₃₀ = −5.66, P < 0.0001). During the luteal phase, the unadjusted difference (t₅₅₀ = −2.83, P = 0.005) was no longer significant after adjustment (t₂₃₄ = −1.69, adjusted P = 0.09).
  • In 15 women, insulin significantly decreased hypothalamic cerebral blood flow in the follicular phase (t₁₄ = −2.57, P = 0.02) but not the luteal phase (t₁₄ = −0.467, P = 0.648); the cycle phase × spray interaction was not significant (P = 0.5).
  • The estradiol:progesterone ratio interacted with spray and time on glucose infusion rate (t₂₁₀ = −2.89, P = 0.004), suggesting a high ratio, as in the follicular phase, is linked to a stronger intranasal insulin effect. Testosterone also showed an interaction (t₁,₀₇₅ = 3.7, P = 0.0002), but calculated free testosterone did not (t₁,₀₇₅ = 0.37, P = 0.7).

Methods

  • Two study populations: 11 healthy naturally cycling women underwent four hyperinsulinemic–euglycemic clamps, two in the follicular and two in the luteal phase, in a single-blind crossover design with nasal insulin (160 U) versus placebo plus an intravenous insulin bolus to mimic spillover; primary endpoint was change in glucose infusion rate.
  • 15 women underwent one fMRI session per cycle phase in a within-subject design; hypothalamic cerebral blood flow was measured with pulsed arterial spin labelling before and 30 min after 160 U nasal insulin, without a placebo control.
  • Dynamic outcomes were modelled with linear mixed models testing time × spray × phase interactions, with adjustment for plasma glucose and insulin where indicated; hypothalamic CBF was compared by two-sided paired t-tests.

Limitations

  • Stated by the paper: limited participant numbers, no women taking oral contraceptives, small differences with large confidence intervals, and need for replication; nasal insulin is not the physiological route; unstable d-[6,6-²H₂]-glucose tracer enrichment prevented separating endogenous glucose production from glucose disappearance; clamp experiments were single-blind, with investigators aware of condition; the fMRI experiment lacked placebo administration.
  • Stated by the paper: the limited sample size may explain why differences in hypothalamic insulin response did not reach statistical significance, while significant spray × cycle phase interactions were detected in the clamp experiments.
  • Evident from the text: the fMRI study found phase-specific hypothalamic effects but no significant cycle phase × spray interaction (P = 0.5), so the neuroimaging result is suggestive rather than confirmatory.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s42255-023-00869-w

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Study outline. a,b, Timeframes of the experiments in the follicular and luteal phases of the menstrual cycle for the clamp study (a) and the fMRI study (b). See also CONSORT diagrams in Extended Data Figs. 3 and 4 for the detailed study flow.
Fig. 1 Study outline. a,b, Timeframes of the experiments in the follicular and luteal phases of the menstrual cycle for the clamp study (a) and the fMRI study (b). See also CONSORT diagrams in Extended Data Figs. 3 and 4 for the detailed study flow.CC BY · PubMed Central
Fig. 2 Impact of insulin versus placebo spray on glucose infusion rates in both phases of the menstrual cycle. a,b, Absolute changes in glucose infusion rates after administration of intranasal insulin (filled circles) or intranasal placebo and i.v. insulin bolus (open circles). Results in the follicular (a) and luteal (b) phases are shown. P values are for time × spray interactions tested by two-sided linear mixed models adjusted for serum insulin and glucose; presented are means, and error bars represent s.e.m.; N = 11 participants except for the follicular phase where N = 10 for the insulin spray.
Fig. 2 Impact of insulin versus placebo spray on glucose infusion rates in both phases of the menstrual cycle. a,b, Absolute changes in glucose infusion rates after administration of intranasal insulin (filled circles) or intranasal placebo and i.v. insulin bolus (open circles). Results in the follicular (a) and luteal (b) phases are shown. P values are for time × spray interactions tested by two-sided linear mixed models adjusted for serum insulin and glucose; presented are means, and error bars represent s.e.m.; N = 11 participants except for the follicular phase where N = 10 for the insulin spray.CC BY · PubMed Central
Fig. 3 Hypothalamic response to insulin spray in both phases of the menstrual cycle. a, Hypothalamus region of interest in coronal (top), sagittal (middle) and axial section planes (bottom). b, Absolute changes in CBF in the hypothalamus from before treatment to 30 min after intranasal insulin administration in the follicular (left) and luteal (right) phases of the menstrual cycle. In the follicular phase, insulin induced a significant reduction in hypothalamic CBF, whereas this effect was absent in the luteal phase. Bar graphs are shown with means and individual data points, and error bars represent s.e.m. Data were analysed by two-sided paired t-tests; *P = 0.02; N = 15 participants in both cycle phases.
Fig. 3 Hypothalamic response to insulin spray in both phases of the menstrual cycle. a, Hypothalamus region of interest in coronal (top), sagittal (middle) and axial section planes (bottom). b, Absolute changes in CBF in the hypothalamus from before treatment to 30 min after intranasal insulin administration in the follicular (left) and luteal (right) phases of the menstrual cycle. In the follicular phase, insulin induced a significant reduction in hypothalamic CBF, whereas this effect was absent in the luteal phase. Bar graphs are shown with means and individual data points, and error bars represent s.e.m. Data were analysed by two-sided paired t-tests; *P = 0.02; N = 15 participants in both cycle phases.CC BY · PubMed Central
Extended Data Fig. 1 Results from the hyperinsulinemic-euglycemic clamp study – individual courses of serum insulin around nasal insulin administration / mimicking by iv insulin bolus. Presented are the individual courses of serum insulin during the clamp after intranasal insulin spray (green and orange circles) vs placebo spray combined with simultaneous iv insulin bolus (yellow and blue circles) in both phases of the menstrual cycle. Presented are individual data points; N = 11 participants except for the follicular phase where N = 10 for the insulin spray.
Extended Data Fig. 1 Results from the hyperinsulinemic-euglycemic clamp study – individual courses of serum insulin around nasal insulin administration / mimicking by iv insulin bolus. Presented are the individual courses of serum insulin during the clamp after intranasal insulin spray (green and orange circles) vs placebo spray combined with simultaneous iv insulin bolus (yellow and blue circles) in both phases of the menstrual cycle. Presented are individual data points; N = 11 participants except for the follicular phase where N = 10 for the insulin spray.CC BY · PubMed Central
Extended Data Fig. 2 Results from the hyperinsulinemic-euglycemic clamp study – individual courses of plasma glucose around nasal insulin administration / mimicking by iv insulin bolus. Presented are the individual courses of plasma glucose during the clamp after intranasal insulin spray (green and orange circles) vs placebo spray combined with simultaneous iv insulin bolus (yellow and blue circles) in both phases of the menstrual cycle. Presented is a dot plot with means; error bars represent SEM; N = 11 participants except for the follicular phase where N = 10 for the insulin spray.
Extended Data Fig. 2 Results from the hyperinsulinemic-euglycemic clamp study – individual courses of plasma glucose around nasal insulin administration / mimicking by iv insulin bolus. Presented are the individual courses of plasma glucose during the clamp after intranasal insulin spray (green and orange circles) vs placebo spray combined with simultaneous iv insulin bolus (yellow and blue circles) in both phases of the menstrual cycle. Presented is a dot plot with means; error bars represent SEM; N = 11 participants except for the follicular phase where N = 10 for the insulin spray.CC BY · PubMed Central
Extended Data Fig. 3 CONSORT flow diagram - hyperinsulinemic-euglycemic clamp study. CONSORT flow chart of the study course of the hyperinsulinemic-euglycemic clamp study.
Extended Data Fig. 3 CONSORT flow diagram - hyperinsulinemic-euglycemic clamp study. CONSORT flow chart of the study course of the hyperinsulinemic-euglycemic clamp study.CC BY · PubMed Central
Extended Data Fig. 4 CONSORT flow diagram – fMRI study. CONSORT flow chart of the study course of the fMRI study.
Extended Data Fig. 4 CONSORT flow diagram – fMRI study. CONSORT flow chart of the study course of the fMRI study.CC BY · PubMed Central

Verification

Claims the paper makes

12 Valid · 0 Not valid · 36 Not checked · 94 Own results and interpretations

69 more claims

Create a free account to see all 142 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 50
  • It may state two separate claims as one. 32

Create a free account to see these claims.

Citations

Cites

Show all 47 references

Cited by

See all 48

Metadata

Authors
Hummel, J., Benkendorff, C., Fritsche, L., Prystupa, K., Vosseler, A., Gancheva, S., Trenkamp, S., Birkenfeld, A. L., Preissl, H., Roden, M., Häring, H.-U., Fritsche, A., Peter, A., Wagner, R., Kullmann, S., & Heni, M.
Affiliations
  • Universität Ulm (DE)
  • University of Tübingen (DE)
  • Helmholtz Munich (DE)
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • German Center for Diabetes Research (DE)
  • Düsseldorf University Hospital (DE)
Corresponding author
Heni, Martin
Venue
Nature Metabolism
Published
2023-09-21
Volume
5
Issue
9
Pages
1475-1482
ISSN
2522-5812 (ISSN-L)
OpenAlex
W4386917918
Cited by
48
References
49
Citations by year
2026: 16 · 2025: 15 · 2024: 13 · 2023: 4
FWCI
7.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
  • Universitätsbibliothek Tübingen
Funders
German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
peripheral insulin sensitivity, menstrual cycle, follicular phase, luteal phase, intranasal insulin, hyperinsulinemic-euglycemic clamp, glucose infusion rate, hypothalamus, women, insulin resistance
MeSH terms
Blood Glucose, Brain, Female, Glucose, Humans, Insulin, Insulin Resistance, Male, Menstrual Cycle

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase. https://app.cochat.ai/papers/10.1038/s42255-023-00869-w
The paper
Hummel, J., Benkendorff, C., Fritsche, L., Prystupa, K., Vosseler, A., Gancheva, S., Trenkamp, S., Birkenfeld, A. L., Preissl, H., Roden, M., Häring, H.-U., Fritsche, A., Peter, A., Wagner, R., Kullmann, S., & Heni, M. (2023). Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase. Nature Metabolism. https://doi.org/10.1038/s42255-023-00869-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.